A Phase I Study of BMS-275183 Given on a Daily Schedule in Patients With Advanced Malignancies

Mise à jour : Il y a 4 ans
Référence : NCT00207025

Femme et Homme

Extrait

The purpose of this clinical research study is to learn about the safety and tolerability of daily BMS-275183 in patients with advanced cancer.


Critère d'inclusion

  • Tumors

Liens